Business Development Dermatology Research 
The Pharma Data
NOVEMBER 8, 2020
Almirall strengthens its leadership in medical dermatology by reinforcing its management team in France and obtaining reimbursement in France of Ilumetri ® (tildrakizumab) for treating moderate to severe chronic plaque psoriasis in adults. Investment in Research & Development remained at c. .
pharmaphorum
DECEMBER 9, 2021
After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families. “I I am fascinated by the breadth of my role, which encompasses self-care products, skin health, sustainability and much more.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
AUGUST 17, 2021
Van Naarden has played an essential role in forging the Loxo Oncology at Lilly research and development program and has been critical to the success of its oncology pipeline. Prior to joining Loxo Oncology, Van Naarden served in various biotechnology investment, operations and advisory roles.
The Pharma Data
DECEMBER 17, 2020
He previously spent more than a decade at Medtronic in the company ’ s Minimally Invasive Therapies Group where he served as the global vice president and General Manager of General Surgery, and in various roles working on research, development, and strategy. He spent 27 years at Merck & Co. Immune Regulation – U.K.-based
The Pharma Data
MAY 18, 2021
This business developed positively in the Europe/Middle East/Africa region and in Latin America, partly as a result of higher prices, whereas it shrank in North America, in part due to a license expiration. percent (Fx & portfolio adj.) increase in sales at Soybean Seed & Traits was driven by volume gains in North America.
Pharmaceutical Technology
JANUARY 25, 2023
But that is changing; technological and cultural shifts mean decentralised research – where part or all of a clinical trial is conducted remotely – is on the rise. Decentralisation will enable further expansion as researchers and patients connect across ever greater distances. The world of clinical trials is changing.
Pharmaceutical Technology
JANUARY 25, 2023
But that is changing; technological and cultural shifts mean decentralised research – where part or all of a clinical trial is conducted remotely – is on the rise. Decentralisation will enable further expansion as researchers and patients connect across ever greater distances. The world of clinical trials is changing.
Expert insights. Personalized for you.
52 
Let's personalize your content